Lynda Charters

While current treatments are good, the best is yet to come.

Intraocular drainage surgery may have a future for treating issues.

Consider ideas about outflow pathways, neuroprotection.

Investigators examine long-term effects of therapeutics in infants.

Bascom Palmer Eye Institute will hold its 18th annual meeting, titled Angiogenesis, Exudation, and Degeneration 2021, a virtual event set for February 12-13.

Peptides offering ophthalmologists a potential treatment option for keratitis.

Phakic lenses are proving to be excellent additions to refractive practices.

Results of a survey among ophthalmologists indicate that patients are receiving fewer examinations — with worsening glaucoma, says S. Fabian Lerner, MD, speaking at the Glaucoma 360 New Horizons Forum.

A new therapy provides noninvasive nighttime IOP control by programming the desired pressure into the device, explained John Berdahl, MD, during the New Horizons Forum.

Community involvement, research continue to boost treatment in pediatric population.

According to investigators, a lack of definitive knowledge about the presence of SARS-CoV-2 in corneal tissues has resulted in the recommendation to avoid using corneal tissue for transplantation when the tissue was obtained from donors with COVID-19 that had been confirmed or those who were exposed to COVID-19.

Emerging technology may facilitate individualized care, disease management.

Organization shines spotlight on frontline heroes during ongoing COVID-19 battle.

For ophthalmologists, practice makes perfect in becoming ambidextrous.

The traditional treatment for primary angle-closure (PAC) and PAC glaucoma (PACG) is laser peripheral iridotomy (LPI) to facilitate aqueous outflow followed by medical treatment with drops to decrease the intraocular pressure (IOP).

Sunita Radhakrishnan, MD, in a presentation at the 25th annual Glaucoma Symposium at the Glaucoma 360 virtual annual event, noted that concomitant treatment of both glaucoma and dry eye is key.

Amid the COVID-19 pandemic, the use of hand sanitizers has increased. However, when they are used improperly, hand sanitizers can damage the eyes. Ophthalmologists are now treating young patients who got the liquid in their eyes.

Amid a pandemic, the Glaucoma Research Foundation is holding its annual gala online, funding aspirations for a glaucoma-free world with a goal of raising $1 million.

A new gene therapy for this patient population targets the ND4 gene mutation.

Imaging ciliary muscle details mechanism of accommodation, effects of aging .

Minimally invasive conjunctival surgery option is an efficient procedure.

Nine pediatric patients with Leber congenital amaurosis show visual improvement in clinical trials.

Change can prove to benefit individuals with diabetes, other comorbidities.

A novel ocular corticosteroid is offering hope of quick results for patients.

The American Medical Association is encouraging women to become involved in policy making and educating health care leaders about the barriers women face in their career development.

With several clinical trials underway, ocular therapy is seen as having potential in the treatment of a number of gene-related diseases.

Protocol T Extension Study details methods needed to maintain VA gains over time.

Newest advances improving ophthalmologists’ performance in operating room.

Consistent message, top-of-mind awareness are strategies for growth.

In light of the ongoing COVID-19 pandemic, the Glaucoma Research Foundation will host a virtual Glaucoma 360 annual meeting in 2021.